Pomerantz Law Firm Announces the Filing of a Class Action against Reata Pharmaceuticals, Inc. and Certain Officers - RETA

NEW YORK, Oct. 15, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Reata Pharmaceuticals, Inc. ("Reata" or the "Company") (NASDAQ: RETA) and certain of its officers.   The class action, filed in
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - 5 days ago

Share |